PembrolizumabAutoimmune necrotising myositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1780卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71773-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：282 / 282

相关论文

共 50 条

[41] PembrolizumabAutoimmune limbic encephalitis: case report
Reactions Weekly, 2017, 1668 (1) : 323 - 323
[42] Bevacizumab/pembrolizumabAutoimmune pancreatitis: case report
Reactions Weekly, 2023, 1959 (1) : 144 - 144
[43] PembrolizumabAutoimmune-hepatitis: case report
Reactions Weekly, 2024, 2025 (1) : 388 - 388
[44] AtorvastatinAutoimmune necrotising myositis: 3 case reports
Reactions Weekly, 2020, 1793 (1) : 74 - 74
[45] AtorvastatinAutoimmune necrotising myositis: 3 case reports
Reactions Weekly, 2021, 1839 (1) : 54 - 54
[46] PembrolizumabAutoimmune haemolytic anaemia: case report
Reactions Weekly, 2021, 1878 (1) : 431 - 431
[47] PembrolizumabAutoimmune haemolytic anaemia: case report
Reactions Weekly, 2020, 1788 (1) : 190 - 190
[48] PembrolizumabAutoimmune arthritis and colitis: case report
Reactions Weekly, 2020, 1817 (1) : 269 - 269
[49] PembrolizumabAutoimmune diabetes mellitus: case report
Reactions Weekly, 2024, 2039 (1) : 458 - 458
[50] Ipilimumab/pembrolizumabAutoimmune diabetes: case report
Reactions Weekly, 2019, 1784 (1) : 158 - 158

← 1 2 3 4 5 →